feed,title,long_url,short_url
Benzinga,"Strongbridge Bio's Recorlev US Application For Cushing's Syndrome Under Review, Potential Approval In Early 2022",https://benzinga.com/general/biotech/21/05/21104217/strongbridge-bios-recorlev-us-application-for-cushings-syndrome-under-review-potential-approval-i,https://j.mp/3oaQjzA
